Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Whole-body MRI for Initial Staging, Early Response Assessment and Restaging After Completion of Therapy in Pediatric Hodgkin's Lymphoma.

NCT04005703 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT04005703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04005703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Whole-body MRI for Initial Staging, Early Response Assessment and Restaging After Completion of Therapy in Pediatric Hodgkin's Lymphoma.
Lead sponsor
UMC Utrecht
Phase
Observational
Overall status
Completed
Start date
June 30, 2011
Completion date
September 30, 2020
Enrollment
75 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin's lymphoma